• Benefits of triple therapy consistent regardless of age at asthma onset

    1 month ago - By Healio

    Improvements observed with triple therapy with umeclidinium, fluticasone furoate and vilanterol, and use of a higher fluticasone furoate dose, were consistent regardless of age at asthma onset, according to new data from the CAPTAIN study.
    Njira Lucia Lugogo, MD, clinical associate professor at the University of Michigan Ann Arbor, presented a new post hoc analysis of the CAPTAIN study looking at the effects of age of asthma onset as a continuous variable on treatment outcomes at the CHEST Annual Meeting.
    The once-daily, single-inhaler triple therapy combines
    Read more ...